Uncoupling the dopamine D1-D2 receptor complex: a novel target for antidepressant treatment.

A H C Wong, F Liu

Department of Neuroscience, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Clinical pharmacology and therapeutics 2012 Feb

filter terms:

Depression, or major depressive disorder (MDD), is a serious mental illness that causes substantial worldwide disability. Current antidepressant medications mostly target the serotonin and norepinephrine neurotransmitter systems. These drugs are ineffective in many patients, and there are limited options for treatment-resistant depression. The dopamine neurotransmitter system has recently been identified as another modulator of mood and depressive symptoms, and a recently discovered interaction between the dopamine D1 and D2 receptor may be a novel antidepressant target.

Citation

A H C Wong, F Liu. Uncoupling the dopamine D1-D2 receptor complex: a novel target for antidepressant treatment. Clinical pharmacology and therapeutics. 2012 Feb;91(2):298-302